June Is Cancer Immunotherapy Month
In recognition of June as Cancer Immunotherapy Month, organized by our colleagues at the Cancer Research Institute (CRI), the...
In recognition of June as Cancer Immunotherapy Month, organized by our colleagues at the Cancer Research Institute (CRI), the...
For the third year running, the American Association for Cancer Research (AACR) has been selected as the beneficiary of...
Last week, the U.S. Food and Drug Administration (FDA) added a new therapeutic to the armamentarium for oncologists treating...
Immunotherapy is revolutionizing the treatment of cancer. As discussed in an earlier post on this blog, immunotherapeutics that work...
Cancer health disparities are driven by the compounding of multiple factors, including gaps in research resulting from insufficient representation...
Guest Post by Graham A. Colditz, MD, DrPH Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School...
Lymphomas are a collection of blood cancers stemming from aberrant lymphocytes, which are critical components of the immune system....
The 30th Anniversary AACR Special Conference Convergence: Artificial Intelligence, Big Data, and Prediction in Cancer is focusing on a...
Conference co-chair Elaine R. Mardis, PhD, discusses the third conference in the AACR's Precision Medicine Series, “Integrating Clinical Genomics...
Every two minutes, a woman somewhere in the world dies of cervical cancer. That harrowing statistic, shared by Anna R....
In the fall issue, Cancer Today had the honor of highlighting two women whose cancer diagnoses led them to...
A highly complex filtering system, the kidneys process roughly half a cup of blood every minute, isolating waste and...
Back for the month of February is our regular staple, Editors’ Picks, which features the “must read” articles that...
Researchers developed a model that uses the gut microbiome to predict if a patient's tumor would have a response...
There’s a quiet corner of the San Diego Convention Center where snacks and toys are plentiful, and naps are...
A career in industry is becoming less an alternative and more a conventional career choice. One scientist explains how...
Breast cancer is the most common cancer among women in the United States and worldwide, with an estimated 2.1 million women diagnosed each year....
This month, the editors of the AACR’s journals have decided to feature a clinical trial evaluating prolonged treatment with ibrutinib for patients with chronic...
Insights from the AACR Cancer Disparities Progress Report 2024.
Roughly 6 percent of men and women in the United States will be diagnosed with lung and bronchus cancer...
Progress against cancer has been fueled not by a single discipline or a sole blockbuster discovery, but by incremental...
On the heels of the U.S. Food and Drug Administration’s approval of a combination of immune checkpoint inhibitors for...
Guest Post by Carlos S. Moreno, PhD Winship Cancer Institute of Emory University
Television series like CSI: Crime Scene Investigation familiarized viewers with advances in forensic science that allow investigators to detect...
Data presented at the AACR Annual Meeting 2016, on April 19, showed that a microdevice about the size of...
On Monday, the U.S. Food and Drug Administration (FDA) announced good news for a subgroup of patients with ovarian...
Last week, the U.S. Food and Drug Administration (FDA) increased the number of cancer types for which immunotherapeutics known...
As we say goodbye to summer, enjoy the selection of articles handpicked by the editors of the AACR journals...
This quarter's round-up of cutting-edge cancer research includes a way to fight chemo brain, controlling cancer cell death, and...
Although a basic assumption of genetics is that all the cells in our body share the same DNA, research...